Announcement IL

Jazz Pharms., Inc. v. Avadel CNS Pharms., LLC

Announcement from a bar association

Headline as published by Illinois Lawyer Now (ISBA) on Oct 14, 2026; collected by the wire Oct 14, 2026, 12:45 PM ET.

Read at Illinois Lawyer Now (ISBA)

Fed. Cir. Docket Nos. 2024-2274, -2277, -2278 LOURIE, REYNA, TARANTO May 6, 2025 Avadel filed a 505(b)(2) “paper NDA” (AstraZeneca, FC 2010; Takeda, FC 2015) for its Lumryz product, a sodium oxybate formulation for the treatment of excessive daytime sleepiness (“EDS”) and cataplexy in adults with narcolepsy. Jazz asserted infringement of claim 24 of U.S.... Continue Reading

From Illinois Lawyer Now (ISBA)’s feed

Coverage

  1. Illinois Lawyer Now (ISBA) Bar associations

    Jazz Pharms., Inc. v. Avadel CNS Pharms., LLC

Topics

  • Bar and practice newsFrom the publisher’s section: no phrase in the text matched, so the tag comes from where Illinois Lawyer Now (ISBA) filed it.

Explore the named firms, organizations and MDL dockets above. Sources and method